Dynavax Technologies Corporation (DVAX)
NASDAQ: DVAX · Real-Time Price · USD
13.33
0.00 (0.00%)
Feb 21, 2025, 4:00 PM EST - Market closed
Dynavax Technologies Employees
Dynavax Technologies had 408 employees as of December 31, 2023. The number of employees increased by 57 or 16.24% compared to the previous year.
Employees
408
Change (1Y)
57
Growth (1Y)
16.24%
Revenue / Employee
$679,525
Profits / Employee
$66,934
Market Cap
1.65B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
DVAX News
- 1 day ago - Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance - PRNewsWire
- 2 days ago - Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy - PRNewsWire
- 3 days ago - Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting - Business Wire
- 3 days ago - Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors - Reuters
- 11 days ago - Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty - Benzinga
- 15 days ago - Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 - PRNewsWire
- 26 days ago - Dynavax Advances Board Refreshment Program - PRNewsWire